19874470

Source:http://linkedlifedata.com/resource/pubmed/id/19874470

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0011900, umls-concept:C0030705, umls-concept:C0085278, umls-concept:C0449259
pubmed:issue	2
pubmed:dateCreated	2010-2-19
pubmed:abstractText	The characteristics and the clinical course of antiphospholipid syndrome (APS) in high-risk patients that are positive for all three recommended tests that detect the presence of antiphospholipid (aPL) antibodies have not been described.
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/19874470-19912514
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/101170508
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Anticardiolipin, http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Antiphospholipid, http://linkedlifedata.com/resource/pubmed/chemical/Anticoagulants, http://linkedlifedata.com/resource/pubmed/chemical/Biological Markers, http://linkedlifedata.com/resource/pubmed/chemical/Lupus Coagulation Inhibitor, http://linkedlifedata.com/resource/pubmed/chemical/beta 2-Glycoprotein I
pubmed:status	MEDLINE
pubmed:month	Feb
pubmed:issn	1538-7836
pubmed:author	pubmed-author:BanzatoAA, pubmed-author:BarcellonaDD, pubmed-author:BisonEE, pubmed-author:DenanBB, pubmed-author:ErbeRR, pubmed-author:GreselePP, pubmed-author:IlicetoSS, pubmed-author:LegnaniCC, pubmed-author:MarongiuFF, pubmed-author:Padayattil JoseSS, pubmed-author:PengoVV, pubmed-author:RuffattiAA, pubmed-author:TestaSS
pubmed:issnType	Electronic
pubmed:volume	8
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	237-42
pubmed:dateRevised	2010-11-18
pubmed:meshHeading	pubmed-meshheading:19874470-Administration, Oral, pubmed-meshheading:19874470-Adult, pubmed-meshheading:19874470-Aged, pubmed-meshheading:19874470-Antibodies, Anticardiolipin, pubmed-meshheading:19874470-Antibodies, Antiphospholipid, pubmed-meshheading:19874470-Anticoagulants, pubmed-meshheading:19874470-Antiphospholipid Syndrome, pubmed-meshheading:19874470-Biological Markers, pubmed-meshheading:19874470-Catastrophic Illness, pubmed-meshheading:19874470-Disease Progression, pubmed-meshheading:19874470-Female, pubmed-meshheading:19874470-Hemorrhage, pubmed-meshheading:19874470-Humans, pubmed-meshheading:19874470-Incidence, pubmed-meshheading:19874470-Italy, pubmed-meshheading:19874470-Kaplan-Meier Estimate, pubmed-meshheading:19874470-Lupus Coagulation Inhibitor, pubmed-meshheading:19874470-Male, pubmed-meshheading:19874470-Middle Aged, pubmed-meshheading:19874470-Predictive Value of Tests, pubmed-meshheading:19874470-Pregnancy, pubmed-meshheading:19874470-Pregnancy Complications, Cardiovascular, pubmed-meshheading:19874470-Proportional Hazards Models, pubmed-meshheading:19874470-Recurrence, pubmed-meshheading:19874470-Retrospective Studies, pubmed-meshheading:19874470-Risk Assessment, pubmed-meshheading:19874470-Risk Factors, pubmed-meshheading:19874470-Time Factors, pubmed-meshheading:19874470-Treatment Outcome, pubmed-meshheading:19874470-Venous Thromboembolism, pubmed-meshheading:19874470-beta 2-Glycoprotein I
pubmed:year	2010
pubmed:articleTitle	Clinical course of high-risk patients diagnosed with antiphospholipid syndrome.
pubmed:affiliation	Clinical Cardiology, Thrombosis Center, University Hospital, Padova, Italy. vittorio.pengo@unipd.it
pubmed:publicationType	Journal Article, Multicenter Study